Table 4. Number and proportion of rats with positive microbiological growth for strains of vancomycin-resistant Enterococcus in organs or tissues.
Groups | |||||
Organ/Tissue | I | II | III | IV | P |
n = 15 | n = 15 | n = 8 | n = 8 | ||
Lung | 11 (73%) | 11 (73%) | 5 (63%) | 3 (38%) | 0.31 |
Spleen | 6 (40%) | 5 (33%) | 2 (25%) | 0 | 0.22 |
Liver | 11 (73%) | 8 (53%) | 8 (100%) | 3 (38%) | 0.04 * |
Portal Blood | 2/12 (17%) | 1 (6%) | 0/7 | 1 (13%) | 0.65 |
Systemic Blood | 2/12 (17%) | 0 | 0 | 0 | 0.14 |
Mesenteric lymph nodes | 10 (67%) | 2 (13%) | 3 (38%) | 0 | 0.002 ** |
Cervical lymph nodes | 5/12 (33%) | 4 (27%) | 1 (13%) | 1 (13%) | 0.59 |
I - surgical group with hepatic ischemia and intestinal stasis; II - surgical group with hepatic ischemia without intestinal stasis; III - surgical control group; IV - non-surgical control group.
*Fisher’s test comparing groups: II and III p:0.03; III and IV p:0.01.
**Fisher’s test comparing groups: I and IV p:0.003; I and II p:0.004.